Methylation as a biomarker for head and neck cancer

Lídia Maria Rebolho Batista Arantes(Faculdade de Medicina de São José do Rio Preto), Ana Carolina de Carvalho(Hospital de Câncer de Barretos), Matias Eliseo Melendez(Hospital de Câncer de Barretos), André Lopes Carvalho(Hospital de Câncer de Barretos), Eny Maria Goloni‐Bertollo(Faculdade de Medicina de São José do Rio Preto)

Oral Oncology

March 22, 2014

10.1016/j.oraloncology.2014.02.015

Cited by 104

Abstract

Related Papers

Epigenetics in Cancer

Manel Esteller|New England Journal of Medicine|2008|3.6k

Epigenetic modifications and human disease

Anna Portela, Manel Esteller|Nature Biotechnology|2010|2.9k

A gene hypermethylation profile of human cancer.

Manel Esteller, Paul G. Corn, Stephen B. Baylin et al.|PubMed|2001|2k

Natural history of potentially malignant oral lesions and conditions: an overview of the literature

Séamus S. Napier, Paul M. Speight|Journal of Oral Pathology and Medicine|2007|619

Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.

Montse Sánchez‐Céspedes, Manel Esteller, Li Wu et al.|PubMed|2000|548